131 related articles for article (PubMed ID: 9811167)
21. Mediation of endothelin-1-induced inhibition of platelet aggregation via the ETB receptor.
McMurdo L; Lidbury PS; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Jun; 109(2):530-4. PubMed ID: 8358553
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
23. Endothelin receptor blockade attenuates air embolization-induced pulmonary hypertension in sheep.
Miyahara T; Koizumi T; Kubo K; Hanaoka M; Kaneki T; Yamamoto H; Ge RL; Fujimoto K; Kobayashi T; Shibamoto T
Eur J Pharmacol; 1999 Dec; 385(2-3):163-9. PubMed ID: 10607872
[TBL] [Abstract][Full Text] [Related]
24. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
[TBL] [Abstract][Full Text] [Related]
25. Endothelium-dependent relaxations in sheep pulmonary arteries and veins: resistance to block by NG-nitro-L-arginine in pulmonary hypertension.
Kemp BK; Smolich JJ; Ritchie BC; Cocks TM
Br J Pharmacol; 1995 Nov; 116(5):2457-67. PubMed ID: 8581285
[TBL] [Abstract][Full Text] [Related]
26. Endothelin and blood pressure regulation in the female rat: studies in normal pregnancy and with nitric oxide synthase inhibition-induced hypertension.
Thaete LG; Neerhof MG
Hypertens Pregnancy; 2000; 19(2):233-47. PubMed ID: 10877991
[TBL] [Abstract][Full Text] [Related]
27. Contribution of endothelin to the acute pressor response of L-NAME in stroke-prone spontaneously hypertensive rats.
Fink J; Fan NY; Rosenfeld L; Stier CT
J Cardiovasc Pharmacol; 1998 Apr; 31(4):618-22. PubMed ID: 9554813
[TBL] [Abstract][Full Text] [Related]
28. The selective endothelin ETA receptor antagonist FR139317 inhibits neointimal thickening in the rat.
Takiguchi Y; Sogabe K
Eur J Pharmacol; 1996 Aug; 309(1):59-62. PubMed ID: 8864694
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of endothelin (ET-1) induced pressor responses by the endothelin (ETA) receptor antagonist FR139317 in the pithed rat.
Sun XY; Hedner T; Feng Q; Edvinsson L
Blood Press; 1992 Aug; 1(2):108-12. PubMed ID: 1366258
[TBL] [Abstract][Full Text] [Related]
30. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition.
Verhagen AM; Rabelink TJ; Braam B; Opgenorth TJ; Gröne HJ; Koomans HA; Joles JA
J Am Soc Nephrol; 1998 May; 9(5):755-62. PubMed ID: 9596072
[TBL] [Abstract][Full Text] [Related]
31. Role of endothelin-1 and the ETA receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension.
Fujita K; Matsumura Y; Kita S; Miyazaki Y; Hisaki K; Takaoka M; Morimoto S
Br J Pharmacol; 1995 Mar; 114(5):925-30. PubMed ID: 7780646
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.
Thaete LG; Neerhof MG; Silver RK
J Soc Gynecol Investig; 2001; 8(1):18-23. PubMed ID: 11223352
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of L-NOARG and L-NAME on basal blood flow and ACh-induced vasodilatation in rat diaphragmatic microcirculation.
Chang HY; Chen CW; Hsiue TR
Br J Pharmacol; 1997 Jan; 120(2):326-32. PubMed ID: 9117127
[TBL] [Abstract][Full Text] [Related]
34. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
[TBL] [Abstract][Full Text] [Related]
35. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
Handa RK; Strandhoy JW; Handa SE
Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
[TBL] [Abstract][Full Text] [Related]
36. Influence of renal denervation on renal effects of acute nitric oxide and ETA/ETB receptor inhibition in conscious normotensive rats.
Girchev R; Markova P; Vuchidolova V
J Physiol Pharmacol; 2006 Mar; 57(1):17-27. PubMed ID: 16601312
[TBL] [Abstract][Full Text] [Related]
37. Evidence from receptor antagonists of an important role for ETB receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney.
Wellings RP; Corder R; Warner TD; Cristol JP; Thiemermann C; Vane JR
Br J Pharmacol; 1994 Feb; 111(2):515-20. PubMed ID: 8004396
[TBL] [Abstract][Full Text] [Related]
38. Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Liu Y; Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1998 Aug; 16(8):1165-73. PubMed ID: 9794721
[TBL] [Abstract][Full Text] [Related]
39. The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men.
Schmidt A; Bayerle-Eder M; Pleiner H; Zeisner C; Wolzt M; Mayer G; Schmetterer L
Nitric Oxide; 2001 Aug; 5(4):370-6. PubMed ID: 11485375
[TBL] [Abstract][Full Text] [Related]
40. Role of endothelin ET(A) receptors in the hypertension produced by 4-day L-nitroarginine methyl ester and cyclosporine treatment.
Pollock DM; Polakowski JS; Opgenorth TJ; Pollock JS
Eur J Pharmacol; 1998 Apr; 346(1):43-50. PubMed ID: 9617750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
